Form 4/A for ALMS ALUMIS INC.
Accepted 2024-08-27 00:00:00 ET · period of report 2024-07-01 · accession 0001415889-24-022292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2024-08-27 | 2024-07-01 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $16.00 | +1.56M | 3.27M | +92% | +$25.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | P | A | 1,562,500 | $16.00 | 3,266,498 | I By Samsara BioCapital, L.P. | — | — | (F1) The original Form 4 inadvertently omitted the purchase of shares by Samsara in the Issuer's initial public offering. (F2) Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. |